A Clinical Study to Investigate Safety, Tolerability and Distribution of CHF 6333 After One or After Repeated Inhalation in Patients With Cystic Fibrosis (CF) and in Patients With Non Cystic Fibrosis (NCFB) Bronchiectasis
Clinical trial NCT04010799 · COMPLETED
Trial details
- NCT number
- NCT04010799
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-27
- Primary completion
- 2021-03-08
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.